HCP5 and acute myeloid leukemia: Our study further showed that the degree of infiltration of several immune cell types and the activity of various immune pathways were different among the high- and low-risk AML groups and that HCP5 expression level, but not that of MEG3, had a positive correlation between both immune and stromal scores.